Network's 'it takes a village' approach improves dementia care and informs research, study shows

November 19, 2012, Indiana University

The approach of the Indianapolis Discovery Network for Dementia—with contributions from family members, community advocates, health care systems and researchers—improves dementia care and informs dementia research, according to a new study by researchers from the Regenstrief Institute and the Indiana University Center for Aging Research.

"Collaborative —sensitive to local needs and concerns—combines of all those involved plus technology. Regular face-to-face meetings of caregivers, clinicians and researchers provide invaluable opportunities to balance human need and the flood of information as we develop and deliver new and innovative care," said Regenstrief Institute investigator Malaz Boustani, M.D., MPH, associate director of the IU Center for Aging Research and IU School of Medicine associate professor of medicine. The senior author of the new study in Clinical Interventions in Aging, a peer-reviewed, open-access online journal, Dr. Boustani is founding director of the Indianapolis Discovery Network for Dementia and sees patients at the Wishard Healthy Center.

IDND's interdisciplinary open-source think-tank implementation of innovations short circuits the lengthy—typically 17-years, according to Dr. Boustani—research-to-practice timeline, bringing concepts that improve dementia care to patients in a fraction of that time. This "discovery-to-delivery" approach evolves to meet the changing needs of those it serves.

For example, IDND's Anticholinergic Cognitive Burden Scale, which evaluates the effects of common over-the-counter and prescription drugs on the aging brain, was developed, tested and put into clinical practice within four years. The Healthy Aging Brain Care Monitor, a "blood pressure cuff" for dementia put into patient care within two years of development, functions as a screening, diagnostic and management tool. Both tools are now in worldwide use.

IDND works to halt inappropriate or "bad" medicine; counsel and support families; reduce the cost of care by avoiding unnecessary emergency room visits and hospitalizations; and decreasing the likelihood of long-term care.

"Discovering and testing effective solutions for people with dementia is not enough," Dr. Boustani said. "IDND creates a platform that can be adapted to any locality to disseminate, implement and translate discoveries into practice that will work there—whether a metropolitan area with large, competing health systems like Indianapolis or a totally different environment. Solutions must be localized to be effective, and they can be. Highly competitive organizations like banks collaborate every day to make financial transactions seamless; diverse health care systems surely can find ways to collaborate to improve lives."

A geriatrician, Dr. Boustani focuses on rapid translation of aging brain research discovery into health care delivery using the lens of complexity science, the tools of medical informatics and the methods of public health epidemiology.

IDND resources are available without charge on the network's website at http://www.indydiscoverynetwork.org/.

"As a geriatrician in community practice, the majority of my patients have dementia. Our close linkage with the researchers at the University through IDND has allowed me to utilize newly developed clinically useful tools early in their development and to provide feedback on their applicability to my patient population," said Patrick Healey, M.D., St. Vincent Health Network.

"The IDND offers a model of collaboration that communities across the country can use to rapidly improve the quality of life for people with dementia and their families. More generally, this is a framework that foundations, government agencies, and organizations can support to ensure the relevance and real-world application of scientific research," said Marcus R. Escobedo, MPA, John A. Hartford Foundation program officer. The foundation is America's leading philanthropy with a sustained interest in aging and health.

Explore further: Regenstrief extending successful aging brain care model globally

More information: The article can be found at www.dovepress.com/articles.php?article_id=11537

Related Stories

Regenstrief extending successful aging brain care model globally

May 2, 2012
The resources developed for an innovative collaborative model of dementia care, which reduces emergency room and hospital visits and improves the quality of care for those with dementia, are now available to institutions, ...

Dementia care model that reduces hospitalizations successfully translated into practice

May 31, 2012
An innovative model of dementia care that significantly reduces emergency department visits and hospitalizations, and encourages use of medications that are not harmful to older brains, has now been used to treat over 1,000 ...

Free, user-friendly 'blood pressure cuff' for dementia is reliable and valid: research

June 14, 2012
A new study shows that a practical clinical tool developed by researchers from the Regenstrief Institute and the Indiana University School of Medicine to measure severity of dementia symptoms is reliable and valid. The Healthy ...

Study: Willingness to be screened for dementia varies by age but not by sex, race or income

June 19, 2012
The first study to examine the actual willingness of older adults to be screened for dementia has found that acceptance of screening is pervasive, although it varies by age. However, willingness to be screened for dementia ...

Recommended for you

Anxiety: An early indicator of Alzheimer's disease?

January 12, 2018
A new study suggests an association between elevated amyloid beta levels and the worsening of anxiety symptoms. The findings support the hypothesis that neuropsychiatric symptoms could represent the early manifestation of ...

One of the most promising drugs for Alzheimer's disease fails in clinical trials

January 11, 2018
To the roughly 400 clinical trials that have tested some experimental treatment for Alzheimer's disease and come up short, we can now add three more.

Different disease types associated with distinct amyloid-beta prion strains found in Alzheimer's patients

January 9, 2018
An international team of researchers has found different disease type associations with distinct amyloid-beta prion strains in the brains of dead Alzheimer's patients. In their paper published in Proceedings of the National ...

Advances in brain imaging settle debate over spread of key protein in Alzheimer's

January 5, 2018
Recent advances in brain imaging have enabled scientists to show for the first time that a key protein which causes nerve cell death spreads throughout the brain in Alzheimer's disease - and hence that blocking its spread ...

Molecular mechanism behind HIV-associated dementia revealed

January 5, 2018
For the first time, scientists have identified and inhibited a molecular process that can lead to neurodegeneration in patients with HIV, according to a Northwestern Medicine study published in Nature Communications.

Mice with frequent flier miles advance the Alzheimer's cause

January 4, 2018
Alzheimer's disease wreaks emotional havoc on patients, who are robbed of their memories, their dignity, and their lives. It's financially devastating as well: care for Alzheimer's patients is predicted to top $1 trillion ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.